Multi-gene testing at point of diagnosis can save all women with breast cancer

[News]

A lifetime model evaluating the financial, health and social impact of multi-gene testing (BRCA1/2/PALB2) at diagnosis for all breast cancer patients was found to be extremely cost effective for both UK and US health systems.

More... (https://www.news-medical.net/news/20191003/Multi-gene-testing-at-point-of-diagnosis-can-save-all-women-with-breast-cancer.aspx)